Effect of ABCB1 (3435C&gt;T) and CYP3A5 (6986A&gt;G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients

Marwa Helal; Manar Obada; Wael Abd Elrazek; Manal Safan; Tarek Abd El-Hakim; Hala El-Said

doi:10.1016/j.ejmhg.2016.10.005

Q2 2017

Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients

Marwa Helal · Manar Obada · Wael Abd Elrazek · Manal Safan · Tarek Abd El-Hakim · Hala El-Said

10.1016/j.ejmhg.2016.10.005 387 Views 10 Citations

Citations

387

Views

Abstract not available for this publication.

Cite this Article (APA)

Marwa, H., Manar, O., Wael, A. E., Manal, S., Tarek, A. E., Hala, E. (2017). Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients. Egyptian Journal of Medical Human Genetics. https://doi.org/10.1016/j.ejmhg.2016.10.005

Effect of ABCB1 (3435C&gt;T) and CYP3A5 (6986A&gt;G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients

Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients